Video Experimental Relacionado

Updated: May 1, 2026

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

Solace, un agente conversacional terapéutico para el manejo del dolor crónico: estudio de aceptabilidad y usabilidad

P Maxwell Slepian^1,2,3,4, Stephanie Buryk-Iggers¹, Anna M Lomanowska¹

¹Department of Anesthesia and Pain Management, University Health Network, 3 EN 317A200 Elizabeth St., Toronto, CA.

JMIR rehabilitation and assistive technologies

|February 19, 2026

Resumen

Un nuevo agente conversacional de IA generativa, Solace, muestra ser prometedor para el manejo del dolor crónico. Esta herramienta de salud digital es utilizable, aceptable y mejora los resultados de los pacientes, lo que justifica la realización de más ensayos clínicos.

Área de la Ciencia:

Intervenciones de salud digital
Inteligencia artificial en la atención médica
Psicología del dolor

Sus antecedentes:

El dolor crónico afecta a millones de personas, con opciones de tratamiento limitadas.
La salud digital ofrece soluciones escalables para el manejo del dolor.
Los agentes conversacionales de IA generativa son un enfoque novedoso para el tratamiento del dolor.

Objetivo del estudio:

Desarrollar y probar Solace, un agente conversacional de IA para el dolor crónico.
Evaluar la usabilidad y aceptabilidad de Solace en pacientes con dolor crónico.
Evaluar la alianza terapéutica formada con el agente de IA.

Principales métodos:

Se realizó un estudio de aceptabilidad y usabilidad con 175 pacientes con dolor crónico.
Los participantes interactuaron con Solace durante al menos 25 minutos.
Las medidas incluyeron la usabilidad del sistema, la aceptabilidad del tratamiento, la alianza terapéutica y los resultados relacionados con el dolor.

Principales resultados:

Solace demostró una usabilidad y aceptabilidad excelentes.
Se reportó una alta alianza terapéutica entre los usuarios y Solace.
Los participantes mostraron mejoras en la ansiedad, la interferencia del dolor, la quinesiofobia y la resiliencia al dolor.

Conclusiones:

Solace es un agente de IA utilizable y aceptable para el manejo del dolor.
El agente de IA facilitó una fuerte alianza terapéutica.
Son necesarios ensayos clínicos aleatorizados adicionales para confirmar la eficacia.

Palabras clave:

IA generativa salud digital manejo del dolor crónico agente conversacional terapéutica

Más Videos Relacionados

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

Novel Surgical Rodent Model for Studying Neuroma Pain Treatment Options using Targeted Muscle Reinnervation Through the Saphenous Nerve

Novel Surgical Rodent Model for Studying Neuroma Pain Treatment Options using Targeted Muscle Reinnervation Through the Saphenous Nerve

Published on: November 14, 2025

Videos de Conceptos Relacionados

Skeletal Muscle Relaxants: Adverse Effects

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...

Peripherally and Centrally Acting Muscle Relaxants: A Comparison

Peripherally and Centrally Acting Muscle Relaxants: A Comparison

Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...

Centrally Acting Muscle Relaxants: Therapeutic Uses

Centrally Acting Muscle Relaxants: Therapeutic Uses

Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...